You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead Jun 28, 2023 at 10:02: AM
Administrator
Staff member
via
- AbbVie may be an active player on the merger and acquisition scene in 2023.
- Blueprint Medicines and Krystal Biotech are two budget-friendly targets.
article source
